Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on May 1, 2024, the Compensation and Talent Committee of Seres board of...
Business Wire•3 months ago